Indian Journal of Chemical Technology

Open Access Open Access  Restricted Access Subscription Access

Effects of Patient-controlled Analgesia Using Dexmedetomidine Combined With Sufentanil on Caesarean Section and Hemodynamics


Affiliations
1 Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province,, China
 

This study evaluates the effects of patient-controlled analgesia (PCA) using dexmedetomidine combined with sufentanil oncaesarean section and maternal hemodynamics. In this study, a total of 140 eligible puerperal are randomly divided into controland experimental groups (n=70). Control group has received PCA using sufentanil, while experimental group has received PCAusing dexmedetomidine plus sufentanil. The analgesic and sedative effects have been evaluated using Bruggemann comfort scale(BCS) score and Ramsay score, respectively. Maternal hemodynamics-related indices heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and oxyhemoglobin saturation (SpO2) have been detected at the end of operation (T0), upon access to analgesic pump (T1), 24 h after access to analgesic pump (T2) and 48h after access to analgesic pump (T3). The incidence rates of postoperative complications were compared. It has been found that at T2 and T3, BCS and Experimental group had significantly higher Ramsay score and lower HR, SBP, DBP and SpO2 than those of control group (P<0.05). The incidence rate of complications in experimental group (5.71%) is found to be significantly lower than that of control group (22.86%) (P<0.05).


Keywords

Dexmedetomidine, Sufentanil, Patient-controlled analgesia, Caesarean section
User
Notifications
Font Size

  • Chiu S N, PediatrNeonatol, 60 (2019) 485.

  • Mian P, Dallmann A, van den Anker J N, Tibboel D &Allegaert K, Pain Med, 20 (2019) 2329.

  • Bergholt T, Skjeldestad F E, Pyykönen A, Rasmussen S C, Tapper A M &Bjarnadóttir R I, ActaObstetGyn Scan, 99 (2020) 283.

  • Uppal V, Retter S, Casey M, Sancheti S, Matheson K &McKeen D M, AnesthAnalg, 130 (2020) 111.

  • Campos-Baeta Y, Saavedra-Mitjans M, Garin N, Cardenete J, Cardona D &Riera P, NutrClinPract, 35 (2020) 967.

  • Murugan E, Rani D P G, Srinivasan K & Muthumary J, Expert Opin Drug Deliv,10 (2013) 1319

  • Muhammad I & Samoylenko V, Expert Opin Drug Discov,2 (2007) 1065.

  • Yogaraj V, Gowtham G, Akshata C R, Manikandan R, Murugan E &Arumugam M, J Drug DelivSciTechnol, 58 (2020) 101785.

  • Murugan E, Rani D P G & Yogaraj V, Colloids Surfaces B Biointerfaces,114 (2014) 121.

  • Murugan E, Akshata C R, Yogaraj V, Sudhandiran G &Babu D, Ceram Int, 48 (2022) 16000.

  • Wang C Y, Chen F, Wu J, Fu S Y, Xu X M & Chen J, British J ClinPharmacol, 86 (2020) 85.

  • Nie J J, Sun S & Huang S Q, J Pain Res, 10 (2017) 2649.

  • Shokrpour M, Reza P P S, Sharifi M &Kamali A, Med Arch, 73 (2019) 399.

  • Vamour C, De Jonckheere J, Mestdagh B, Storme L, Richart P &Garabedian C, J GynecolObstet Hum Reprod, 48 (2019) 663.

  • Nie Y, Tu W, Shen X, Yu W, Yu Y & Song X, Sci Rep, 8 (2018) 9952.

  • Verma K, Malawat A, Jethava D &Jethava D D, Indian J Anaesth, 63 (2019) 820.

  • Mulchandani R, Power H S &Cavallaro F L, J ObstetGynaecol, 40 (2020) 1.

  • Cenkowski M J, Maguire D, Kowalski S, A l Gurashi F A & Funk D, Saudi J Anaesth, 13 (2019) 208.

  • Chi X, Li M, Mei W & Liao M, J Pain Res, 10 (2017) 1521.

  • Coates D, Thirukumar P & Henry A, Birth, 47 (2020) 169.

  • Fore M S, Allshouse A A, Carlson N S & Hurt K J, Birth, 47 (2020) 123.

  • Blanc-Petitjean P, Schmitz T, Salom M, Goffinet F &Le Ray C, ActaObstetGynecolScand, 99 (2020) 406.

  • Mäkelä K, Palomäki O, Pokkinen S, Yli-Hankala A, Helminen M &Uotila J, Arch GynecolObstet, 300 (2019) 903.

  • Peng K, Liu H Y, Wu S R, Cheng H &Ji F H, Clin J Pain, 31 (2015) 1097.

  • Wei C N, Chang X Y, Dong J H & Zhou Q H, Front Pharmacol, 11 (2020) 980.

  • Xu Y & Du X, ExpTher Med, 20 (2020) 1269.

  • Imani F, Rahimzadeh P, Faiz H R, Nowruzina S, Shakeri A & Ghahremani M, Anesth Pain Med, 8 (2018) 85311.

  • Zhang L Y, Zhang Y H, Shen J &Luo Y, Ann Palliat Med, 8 (2019) 469.

  • Liu L, Yuan Q, Wang Y, Gao W, Hou J & Wu Y,Med SciMonit, 24 (2018) 8925.


Abstract Views: 116

PDF Views: 91




  • Effects of Patient-controlled Analgesia Using Dexmedetomidine Combined With Sufentanil on Caesarean Section and Hemodynamics

Abstract Views: 116  |  PDF Views: 91

Authors

Wei Li
Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province,, China
Ying Zhang
Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province,, China
Jianrui Lv
Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province,, China
Yong Zhang
Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province,, China
Bin Luo
Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province,, China

Abstract


This study evaluates the effects of patient-controlled analgesia (PCA) using dexmedetomidine combined with sufentanil oncaesarean section and maternal hemodynamics. In this study, a total of 140 eligible puerperal are randomly divided into controland experimental groups (n=70). Control group has received PCA using sufentanil, while experimental group has received PCAusing dexmedetomidine plus sufentanil. The analgesic and sedative effects have been evaluated using Bruggemann comfort scale(BCS) score and Ramsay score, respectively. Maternal hemodynamics-related indices heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and oxyhemoglobin saturation (SpO2) have been detected at the end of operation (T0), upon access to analgesic pump (T1), 24 h after access to analgesic pump (T2) and 48h after access to analgesic pump (T3). The incidence rates of postoperative complications were compared. It has been found that at T2 and T3, BCS and Experimental group had significantly higher Ramsay score and lower HR, SBP, DBP and SpO2 than those of control group (P<0.05). The incidence rate of complications in experimental group (5.71%) is found to be significantly lower than that of control group (22.86%) (P<0.05).


Keywords


Dexmedetomidine, Sufentanil, Patient-controlled analgesia, Caesarean section

References